Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis

@article{Jamnitski2011PrevalenceOC,
  title={Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis},
  author={Anna Jamnitski and Ingrid M Visman and Mike J L Peters and Maarten Boers and B. A. C. Dijkmans and Michael T. Nurmohamed},
  journal={Annals of the Rheumatic Diseases},
  year={2011},
  volume={70},
  pages={875 - 876}
}
The increased risk for cardiovascular disease (CVD) in rheumatoid arthritis (RA) is well known and inflammation appears to play a pivotal aetiological role. There is now substantial interest in whether or not psoriatic arthritis (PsA) is also associated with an enhanced cardiovascular (CV) risk. However, data on CVD in PsA is limited.1,–,3 The aim of this comparative study was to determine the prevalence of non-fatal CVD in patients with PsA compared with patients with RA and to investigate the… 
View on BMJ
dare.ubvu.vu.nl
49 Citations
Highly Influential Citations
1
Background Citations
14
Results Citations
5

49 Citations

Citation Type

Citation Type

Cardiovascular Risk in Patients with Psoriatic Arthritis
TLDR
This paper discusses the current literature indicating that patients with PsA are at risk of cardiovascular diseases and plays a pivotal role in the pathogenesis of atherosclerosis in PsA.
Psoriatic arthritis and risk of overt cardiovascular disease: review of the evidence
TLDR
Questions remain about the role of inflammation in the development of overt CVD, which results in major cardiovascular events such as myocardial infarction and stroke.
Inflammatory arthritis as a novel risk factor for cardiovascular disease.
  • H. John, G. Kitas
  • Biology, Medicine
    European journal of internal medicine
  • 2012
Cardiovascular disease in inflammatory rheumatic diseases.
Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review
TLDR
Most studies point towards an increased cardiovascular risk in PsA, broadly on a par with the risk level in rheumatoid arthritis, emphasising the need for similar cardiovascular risk management in both conditions.
Cardiovascular risk in psoriatic arthritis - a cross-sectional study.
TLDR
Cardiovascular risk of PsA patients estimated on SCORE charts correlates with metabolic clinical and laboratory features and is associated with classical cardiovascular risk factors.
Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database
TLDR
The data can be suggestive of the reduction of the CV risk in patients with PsA treated with Etanercept, and the anti-inflammatory effect of Etnercept is associated with a significant improvement of hemostatic and fibrinolytic parameters in PsA subjects.
Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence
TLDR
The association between psoriasis and PsA and cardiometabolic disorders is discussed, emphasising the need for better consideration of simple lifestyle interventions and a simple and pragmatic test portfolio to screen for cardiovascular risk and metabolic disorders in patients at higher risk is proposed.
High Prevalence of Metabolic Syndrome and of Insulin Resistance in Psoriatic Arthritis is Associated with the Severity of Underlying Disease
TLDR
Among patients with PsA, MetS and IR are highly prevalent, and are independently associated with the severity of underlying PsA.
Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
TLDR
Common educational programs for specialists and general practitioners and appropriate CV prevention programs, taking into consideration traditional VRFs as well as the inflammatory status, should be planned to prevent ischemic events and to achieve optimal inflammation control in rheumatic patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
Cardiovascular morbidity in psoriatic arthritis.
TLDR
In addition to known risk factors for CVD, severe psoriasis is an important predictor in patients with PsA, which is at increased risk of cardiovascular morbidities compared with the general population.
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
TLDR
Cardiovascular diseases and their risk factors were more common in patients with RA, PsA, and AS than in matched controls and use of selected cardiovascular medications was significantly higher in patients than controls.
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation
TLDR
The prevalence of CVD in RA is increased to an extent that is at least comparable to that of DM2, a well-established cardiovascular risk factor, which should have implications for primary cardiovascular prevention strategies in RA.
Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
TLDR
Substantial evidence points to elevated risk of CVD in patients with psoriasis and PsA, and Physicians treating patients with PsA must be aware of all potential cardiovascular risk factors in their patients.
Tackling ischaemic heart disease in rheumatoid arthritis.
TLDR
Using myocardial perfusion SPECT (single photon emission computed tomography) scans under pharmacological stress, it is shown that the prevalence of stable IHD in RA (50%) is twice that in closely matched osteoarthritic controls (27%).
PSORIATIC ARTHRITIS.
TLDR
There is not a strong correlation between the severity of psoriasis and the development of arthritis, although psoriatic arthritis may be present more frequently in patients with Psoriasis attending dermatology clinics, compared to primary care.
Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
TLDR
A significantly higher prevalence of IR is shown in RA patients and a significant association between IR and subclinical atherosclerosis is pointed out, driven primarily by exposure to steroid therapy.
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.
TLDR
Evidence of previously active and severe disease, as manifested by the prior use of medications and by radiologic changes as well as an elevated ESR at presentation, are prognostic indicators for death.
C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study
TLDR
Interleukin-6 appeared as a risk marker of MI-coronary death, and it improved the definition of CHD risk beyond LDL cholesterol, which may reflect the underlying inflammatory reaction located in the atherosclerotic plaque.
Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55–78
  • 1973
...
1
2
...